Lexicon Pharmaceuticals LXRX Amortization Of Financing Costs And Discounts
Amortization Of Financing Costs And Discounts at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's amortization of financing costs and discounts.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's amortization of financing costs and discounts?
- Lexicon Pharmaceuticals (LXRX) reported amortization of financing costs and discounts of $681K in Q1 2026.
- How has Lexicon Pharmaceuticals's amortization of financing costs and discounts changed year-over-year?
- Lexicon Pharmaceuticals's amortization of financing costs and discounts increased by 69.8% year-over-year, from $401K to $681K.
- What is the long-term trend for Lexicon Pharmaceuticals's amortization of financing costs and discounts?
- Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's amortization of financing costs and discounts has grown at a 136.9% compound annual growth rate (CAGR), from $54K to $1.7M.
- What does amortization of financing costs and discounts mean?
- This represents the non-cash expense recognized over the life of a debt instrument related to the issuance costs or original issue discounts. It reflects the systematic allocation of these financing-related costs to interest expense over the term of the borrowing. Investors track this to understand the true effective cost of capital beyond the stated coupon rate.